We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
Turnover
16.03%
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
5.4
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1251
Ford
F
$49.1B
| $672K | ﹤0.01% |
61,915
-8,487
| -12% | -$86.4K |
2013 Q2
48 quarters
|
|
1252
Perspective Therapeutics
CATX
$267M
| $671K | ﹤0.01% |
195,080
+60,019
| +44% | +$158K |
2025 Q1
1 quarter
|
|
1253
Ethan Allen Interiors
ETD
$513M
| $669K | ﹤0.01% |
24,004
+62
| +0.3% | +$1.68K |
2013 Q2
48 quarters
|
|
1254
Chemed
CHE
$6.74B
| $667K | ﹤0.01% |
1,369
-53
| -4% | -$30.2K |
2013 Q2
48 quarters
|
|
1255
Viking Therapeutics
VKTX
$3.48B
| $664K | ﹤0.01% |
+25,072
| New | +$660K |
2025 Q2
0 quarters
|
|
1256
Sezzle
SEZL
$4.47B
| $664K | ﹤0.01% |
3,705
+3,237
| +692% | +$287K |
2024 Q3
3 quarters
|
|
1257
Genpact
G
$6.29B
| $662K | ﹤0.01% |
15,037
-197
| -1% | -$8.92K |
2021 Q2
16 quarters
|
|
1258
Nomad Foods
NOMD
$1.61B
| $662K | ﹤0.01% |
38,949
-10,519
| -21% | -$193K |
2020 Q2
20 quarters
|
|
1259
e.l.f. Beauty
ELF
$6.85B
| $657K | ﹤0.01% |
5,277
-144,649
| -96% | -$12.3M |
2022 Q3
11 quarters
|
|
1260
Rexford Industrial Realty
REXR
$8.23B
| $656K | ﹤0.01% |
18,442
+145
| +0.8% | +$5.06K |
2016 Q4
34 quarters
|
|
1261
Alkermes
ALKS
$6.73B
| $653K | ﹤0.01% |
22,814
-56,776
| -71% | -$1.69M |
2021 Q2
16 quarters
|
|
1262
Entrada Therapeutics
TRDA
$186M
| $650K | ﹤0.01% |
96,686
-2,034
| -2% | -$16.4K |
2023 Q4
6 quarters
|
|
1263
Badger Meter
BMI
$3.68B
| $649K | ﹤0.01% |
2,648
-39
| -1% | -$8.84K |
2023 Q3
7 quarters
|
|
1264
Ategrity Specialty Insurance
ASIC
$1.29B
| $646K | ﹤0.01% |
+30,000
| New | +$687K |
2025 Q2
0 quarters
|
|
1265
Morningstar
MORN
$7.85B
| $643K | ﹤0.01% |
2,048
-67
| -3% | -$19.8K |
2023 Q3
7 quarters
|
|
1266
Rambus
RMBS
$10.1B
| $642K | ﹤0.01% |
10,027
-69
| -0.7% | -$3.7K |
2023 Q4
6 quarters
|
|
1267
Vistance Networks Inc
VISN
$1.36B
| $639K | ﹤0.01% |
77,216
-585,067
| -88% | -$3.06M |
2022 Q2
12 quarters
|
|
1268
Universal Display
OLED
$3.6B
| $637K | ﹤0.01% |
4,126
-54
| -1% | -$7.56K |
2018 Q4
26 quarters
|
|
1269
PDF Solutions
PDFS
$1.74B
| $636K | ﹤0.01% |
29,735
+14,581
| +96% | +$276K |
2025 Q1
1 quarter
|
|
1270
DELISTED
Skechers
SKX
| $634K | ﹤0.01% |
10,046
-2,415
| -19% | -$139K |
2013 Q2
48 quarters
|
|
1271
CryoPort
CYRX
$865M
| $634K | ﹤0.01% |
84,937
+59,446
| +233% | +$369K |
2025 Q1
1 quarter
|
|
1272
Carrier Global
CARR
$45.3B
| $632K | ﹤0.01% |
8,639
+6,677
| +340% | +$453K |
2020 Q2
20 quarters
|
|
1273
Blackbaud
BLKB
$2.33B
| $632K | ﹤0.01% |
9,837
-8,419
| -46% | -$526K |
2017 Q2
32 quarters
|
|
1274
Aveanna Healthcare
AVAH
$2.76B
| $631K | ﹤0.01% |
120,594
+32,679
| +37% | +$166K |
2023 Q4
6 quarters
|
|
1275
Lattice Semiconductor
LSCC
$15.2B
| $630K | ﹤0.01% |
12,853
-253
| -2% | -$12.1K |
2019 Q1
25 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.